CHST15 and neoplasm: The results of this study demonstrate the ability of locally administered, EUS-directed RNA oligonucleotides to suppress tumoral CHST15 expression, thereby increasing the population of tumor-infiltrating T lymphocytes and ultimately optimizing patient prognosis [98].